Bansi Desai
Stock Analyst at J.P. Morgan
(2.75)
# 2,813
Out of 4,595 analysts
66
Total ratings
51.1%
Success rate
3.8%
Average return
Main Sectors:
Stocks Rated by Bansi Desai
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: CIPLA Cipla Limited | Maintained: Buy | ₹1,550 → ₹1,600 | ₹1,472 | +8.70% | 6 | Jul 28, 2026 | |
| NSE: ANTHEM Anthem Biosciences Limited | Maintained: Buy | ₹850.00 → ₹900.00 | ₹810.00 | +11.11% | 4 | Jul 23, 2026 | |
| NSE: ALKEM Alkem Laboratories Limited | Maintained: Hold | ₹6,400 → ₹5,900 | ₹5,735 | +2.88% | 5 | May 29, 2026 | |
| NSE: BLUEJET Blue Jet Healthcare Limited | Maintained: Sell | ₹600.00 → ₹370.00 | ₹624.00 | -40.71% | 4 | May 27, 2026 | |
| NSE: FORTIS Fortis Healthcare Limited | Maintained: Buy | ₹1,050 → ₹1,120 | ₹943.40 | +18.72% | 5 | May 27, 2026 | |
| NSE: DIVISLAB Divi's Laboratories Limited | Maintained: Buy | ₹7,800 → ₹7,400 | ₹8,085 | -8.47% | 2 | May 25, 2026 | |
| NSE: MANKIND Mankind Pharma Limited | Maintained: Buy | ₹2,800 → ₹2,850 | ₹2,472 | +15.29% | 6 | May 22, 2026 | |
| NSE: ZYDUSLIFE Zydus Lifesciences Limited | Maintained: Hold | ₹1,010 → ₹1,050 | ₹1,125 | -6.67% | 4 | May 22, 2026 | |
| NSE: LUPIN Lupin Limited | Maintained: Buy | ₹2,550 → ₹2,600 | ₹2,414 | +7.71% | 5 | Nov 9, 2025 | |
| NSE: DRREDDY Dr. Reddy's Laboratories Limited | Maintained: Sell | ₹1,090 → ₹1,150 | ₹1,146 | +0.39% | 4 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹34,500 → ₹37,000 | ₹27,750 | +33.33% | 5 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,350 → ₹1,550 | ₹1,961 | -20.96% | 3 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,240 → ₹1,480 | ₹1,405 | +5.34% | 2 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹2,030 → ₹1,970 | ₹1,987 | n/a | 4 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,700 → ₹1,840 | ₹1,525 | n/a | 4 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,390 → ₹1,325 | ₹1,101 | n/a | 2 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹8,800 | ₹8,941 | n/a | 1 | Feb 12, 2025 |
Cipla Limited
Jul 28, 2026
Maintained: Buy
Price Target: ₹1,550 → ₹1,600
Current: ₹1,472
Upside: +8.70%
Anthem Biosciences Limited
Jul 23, 2026
Maintained: Buy
Price Target: ₹850.00 → ₹900.00
Current: ₹810.00
Upside: +11.11%
Alkem Laboratories Limited
May 29, 2026
Maintained: Hold
Price Target: ₹6,400 → ₹5,900
Current: ₹5,735
Upside: +2.88%
Blue Jet Healthcare Limited
May 27, 2026
Maintained: Sell
Price Target: ₹600.00 → ₹370.00
Current: ₹624.00
Upside: -40.71%
Fortis Healthcare Limited
May 27, 2026
Maintained: Buy
Price Target: ₹1,050 → ₹1,120
Current: ₹943.40
Upside: +18.72%
Divi's Laboratories Limited
May 25, 2026
Maintained: Buy
Price Target: ₹7,800 → ₹7,400
Current: ₹8,085
Upside: -8.47%
Mankind Pharma Limited
May 22, 2026
Maintained: Buy
Price Target: ₹2,800 → ₹2,850
Current: ₹2,472
Upside: +15.29%
Zydus Lifesciences Limited
May 22, 2026
Maintained: Hold
Price Target: ₹1,010 → ₹1,050
Current: ₹1,125
Upside: -6.67%
Lupin Limited
Nov 9, 2025
Maintained: Buy
Price Target: ₹2,550 → ₹2,600
Current: ₹2,414
Upside: +7.71%
Dr. Reddy's Laboratories Limited
Aug 19, 2025
Maintained: Sell
Price Target: ₹1,090 → ₹1,150
Current: ₹1,146
Upside: +0.39%
Aug 15, 2025
Maintained: Buy
Price Target: ₹34,500 → ₹37,000
Current: ₹27,750
Upside: +33.33%
Aug 11, 2025
Maintained: Hold
Price Target: ₹1,350 → ₹1,550
Current: ₹1,961
Upside: -20.96%
Aug 11, 2025
Maintained: Hold
Price Target: ₹1,240 → ₹1,480
Current: ₹1,405
Upside: +5.34%
Aug 1, 2025
Maintained: Buy
Price Target: ₹2,030 → ₹1,970
Current: ₹1,987
Upside: n/a
Jul 29, 2025
Maintained: Buy
Price Target: ₹1,700 → ₹1,840
Current: ₹1,525
Upside: n/a
May 22, 2025
Maintained: Buy
Price Target: ₹1,390 → ₹1,325
Current: ₹1,101
Upside: n/a
Feb 12, 2025
Maintained: Buy
Price Target: ₹8,800
Current: ₹8,941
Upside: n/a